- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02114515
PATient Navigator to rEduce Readmissions (PArTNER)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- University of Illinois Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 years or older on date of hospital admission
- Hospitalized at the University of Illinois Hospital, Chicago
- Admission diagnosis, per treating physician, of pneumonia, COPD, sickle cell disease, heart failure, or myocardial infarction
- Receive medical care on an inpatient medical service
Exclusion Criteria:
- Unable to understand and speak English
- Unable/decline to give informed consent
- Previous participant in PArTNER
- Planned transfer to another acute care facility
- Planned discharge to facility other than home (e.g. long term care facility)
- Currently on hospice or plans to discharge home to hospice
- Current plans to leave against medical advice
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Usual Care
Hospital usual care Hospital usual care: Written discharge instructions provided to patients prior to hospital discharge. |
Written discharge instructions provided to patients prior to hospital discharge.
|
Experimental: Usual Care + PArTNER
Navigator intervention: (Community health worker, peer-led telephone support line, usual care) Hospital usual care: Written discharge instructions provided to patients prior to hospital discharge. Community health worker: The community health worker provides social support, literacy appropriate education, and acts as a conduit between the patient and the patient's medical team Peer-led telephone support line: The peer-led telephone support line will provide social support, peer-to-peer coaching, and facilitate communication with the patient's medical care team. |
Written discharge instructions provided to patients prior to hospital discharge.
A Patient Navigator will provide social support, literacy appropriate education, and act as a conduit between the patient and the patient's medical team
The peer-led telephone support line will provide social support, peer-to-peer coaching, and facilitate communication with the patient's medical care team.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PROMIS Emotional Distress-Anxiety (v1.0, SF4a)
Time Frame: 30 days post discharge
|
Change in T-score from baseline to 30 days post discharge (30 days minus baseline). A change in t-score <0 indicates improvement. A change equal to 0 indicates no change. A change >0 indicates worsening. |
30 days post discharge
|
PROMIS Informational Support (v2.0, SF4a)
Time Frame: 30 days post discharge
|
Change in T-score from baseline to 30 days post discharge (30 days minus baseline). A change in t-score <0 indicates worsening. A change equal to 0 indicates no change. A change >0 indicates improvement. |
30 days post discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PROMIS Emotional Support (v2.0, SF4a)
Time Frame: 30 days post discharge
|
Change in T-score from baseline to 30 days post discharge (30 days minus baseline). A change in t-score <0 indicates worsening. A change equal to 0 indicates no change. A change >0 indicates improvement. |
30 days post discharge
|
PROMIS Instrumental Support (v2.0, SF4a)
Time Frame: 30 days post discharge
|
Change in T-score from baseline to 30 days post discharge (30 days minus baseline). A change in t-score <0 indicates worsening. A change equal to 0 indicates no change. A change >0 indicates improvement. |
30 days post discharge
|
PROMIS Global Health, Physical (v1.1, SF)
Time Frame: 30 days post discharge
|
Change in T-score from baseline to 30 days post discharge (30 days minus baseline). A change in t-score <0 indicates worsening. A change equal to 0 indicates no change. A change >0 indicates improvement. |
30 days post discharge
|
PROMIS Global Health, Mental (v1.1, SF)
Time Frame: 30 days post discharge
|
Change in T-score from baseline to 30 days post discharge (30 days minus baseline). A change in t-score <0 indicates worsening. A change equal to 0 indicates no change. A change >0 indicates improvement. |
30 days post discharge
|
PROMIS Emotional Distress-Anxiety (v1.0, SF4a)
Time Frame: 60 days post discharge
|
Change in T-score from baseline to 60 days post discharge (60 days minus baseline). A change in t-score <0 indicates improvement. A change equal to 0 indicates no change. A change >0 indicates worsening. |
60 days post discharge
|
PROMIS Informational Support (v2.0, SF4a)
Time Frame: 60 days post discharge
|
Change in T-score from baseline to 60 days post discharge (60 days minus baseline). A change in t-score <0 indicates worsening. A change equal to 0 indicates no change. A change >0 indicates improvement. |
60 days post discharge
|
PROMIS Emotional Support (v2.0, SF4a)
Time Frame: 60 days post discharge
|
Change in T-score from baseline to 60 days post discharge (60 days minus baseline). A change in t-score <0 indicates worsening. A change equal to 0 indicates no change. A change >0 indicates improvement. |
60 days post discharge
|
PROMIS Instrumental Support (v2.0, SF4a)
Time Frame: 60 days post discharge
|
Change in T-score from baseline to 60 days post discharge (60 days minus baseline). A change in t-score <0 indicates worsening. A change equal to 0 indicates no change. A change >0 indicates improvement. |
60 days post discharge
|
PROMIS Global Health, Physical (v1.1, SF)
Time Frame: 60 days post discharge
|
Change in T-score from baseline to 60 days post discharge (60 days minus baseline). A change in t-score <0 indicates worsening. A change equal to 0 indicates no change. A change >0 indicates improvement. |
60 days post discharge
|
PROMIS Global Health, Mental (v1.1, SF)
Time Frame: 60 days post discharge
|
Change in T-score from baseline to 60 days post discharge (60 days minus baseline). A change in t-score <0 indicates worsening. A change equal to 0 indicates no change. A change >0 indicates improvement. |
60 days post discharge
|
Death
Time Frame: 30 days post discharge
|
Caregiver-reported and confirmed by EHR review
|
30 days post discharge
|
Death
Time Frame: 60 days post discharge
|
Caregiver-reported and confirmed by EHR review
|
60 days post discharge
|
Re-hospitalization or Death
Time Frame: 30 days post discharge
|
Confirmed by EHR review
|
30 days post discharge
|
Re-hospitalization or Death
Time Frame: 60 days post discharge
|
Confirmed by EHR review
|
60 days post discharge
|
ED Visit, Re-hospitalization, or Death
Time Frame: 30 days post discharge
|
Confirmed by EHR review
|
30 days post discharge
|
ED Visit, Re-hospitalization, or Death
Time Frame: 60 days post discharge
|
Confirmed by EHR review
|
60 days post discharge
|
Outpatient Healthcare Visit
Time Frame: 14 days post discharge
|
Self-reported
|
14 days post discharge
|
Outpatient Healthcare Visit
Time Frame: 14 days post discharge
|
EHR-reported
|
14 days post discharge
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Jerry A Krishnan, MD, PhD, University of Illinois at Chicago
- Principal Investigator: Elizabeth Calhoun, PhD, University of Arizona
- Principal Investigator: Mark V. Williams, MD, University of Kentucky
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Ischemia
- Pathologic Processes
- Necrosis
- Myocardial Ischemia
- Heart Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Respiratory Tract Diseases
- Lung Diseases
- Hematologic Diseases
- Genetic Diseases, Inborn
- Anemia
- Anemia, Hemolytic, Congenital
- Anemia, Hemolytic
- Hemoglobinopathies
- Myocardial Infarction
- Infarction
- Lung Diseases, Obstructive
- Pulmonary Disease, Chronic Obstructive
- Anemia, Sickle Cell
Other Study ID Numbers
- PCORI-IH 1211-4365
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myocardial Infarction
-
University Medical Centre LjubljanaCompletedCardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Slovenia
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SANot yet recruiting
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
Stiftung Institut fuer HerzinfarktforschungGlaxoSmithKline; University Hospital Muenster; Klinikum NürnbergCompletedMyocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial InfarctionGermany
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Boston Scientific CorporationActive, not recruitingST Elevation Myocardial Infarction | Non ST Elevation Myocardial InfarctionCanada
-
Bispebjerg HospitalOdense University Hospital; Zealand University Hospital; Hvidovre University... and other collaboratorsRecruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Denmark
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
-
University of LeedsUniversity College, LondonCompletedST-elevation Myocardial Infarction | Non ST-elevation Myocardial Infarction
-
Miracor Medical SARecruitingInferior Wall Myocardial Infarction | STEMI - ST Elevation Myocardial InfarctionFrance, United Kingdom, Latvia, Switzerland, Denmark
-
Miracor Medical SAWithdrawnAnterior Wall Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction
Clinical Trials on Hospital usual care
-
Scripps Whittier Diabetes InstituteNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Covid19United States
-
Parc de Salut MarCompletedChronic Obstructive Pulmonary DiseaseSpain
-
National University Health System, SingaporeNational University of SingaporeCompleted
-
University of ChicagoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingHypertension | Chronic Kidney DiseasesUnited States
-
Wenwen YinUnknown
-
Hospital Sao JoaoUnknownChronic Obstructive Pulmonary Disease | Obesity Hypoventilation Syndrome | Neuromuscular Disease | Chest Wall DisordersPortugal
-
Providence Medical Research CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Washington... and other collaboratorsCompletedChronic Kidney Disease | End-Stage Renal DiseaseUnited States
-
St. Olavs HospitalCommunity Health NetworkCompleted
-
Brigham and Women's HospitalThe Thompson Family Foundation IncCompletedHeart Failure | Infections | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Asthma | Anticoagulation | Gout Flare | Hypertensive Urgency | Atrial Fibrillation Rapid | Diabetes and Its Complications | End of Life/Desires Only Medical ManagementUnited States, Canada
-
Weill Medical College of Cornell UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingMyocardial Infarction | Cardiovascular Diseases | Heart Failure | Stroke | Hypertension | Diabetes Mellitus | Atrial Fibrillation | Transient Ischemic Attack | Hyperlipidemias | Ischemic Heart DiseaseUnited States